Non-Invasive Aesthetic Treatment Market
Non-Invasive Aesthetic Treatment Market Study by Injectables and Skin Rejuvenation at Hospitals/Surgery Centers, MedSpas, Traditional Spas, and CHP-Owned Clinics from 2024 to 2034
Analysis of Non-Invasive Aesthetic Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Non-Invasive Aesthetic Treatment Market Outlook (2024 to 2034)
The global non-invasive aesthetic treatment market is projected to reach a size of US$ 39.75 billion in 2024, according to the recently updated market analysis complied by proficient analysts at Fact.MR. Revenue from non-invasive aesthetic treatment solutions is approximated to increase at 20.7% CAGR and reach US$ 260 billion by the end of 2034.
Increasing focus of people around the world on physical appearance is leading to the growing demand for non-invasive aesthetic treatment solutions. Another prominent revenue generator is people from different age groups seeking these procedures, especially those aged 50 and above, particularly women who are opting for injectables and filters, such as Botox. Increasing count of non-invasive cosmetic surgeries due to their reduced downtime and less risk compared to conventional surgical alternatives are creating prospects for market players.
Technological advancements are making non-invasive aesthetic processes more accessible and effective, thereby attracting a larger group of people seeking invasive surgery. Cost-effectiveness, adaptability, and convenience of non-invasive aesthetic treatments compared to conventional beauty treatments ensure noticeable and rapid results with minimal possible recovery time, which further contributes to their increased preference in the aesthetics sector.
Certain challenges are stunting non-invasive aesthetic treatment market growth, such as inconsistent results and high costs. Extremely high costs of these procedures are limiting their demand growth and resulting in patient discontent, which is subsequently limiting their demand.
- North America is evaluated to account for 36.1% of global the non-invasive aesthetic treatment market share by 2034-end.
- Revenue from non-invasive aesthetic treatment in South Korea is forecasted to climb at a CAGR of 21.4% from 2024 to 2034.
- The hospitals/surgery centers segment is analyzed to increase at 22.3% CAGR and reach a market value of US$ 120.58 billion by the end of 2034.
| Report Attribute | Detail |
|---|---|
| Non-Invasive Aesthetic Treatment Market Size (2024E) | US$ 39.75 Billion |
| Forecasted Market Value (2034F) | US$ 260 Billion |
| Global Market Growth Rate (2024 to 2034) | 20.7% CAGR |
| India Market Growth Rate (2024 to 2034) | 29.4% CAGR |
| Market Share of Injectables (2034F) | 66.9% |
| South Asia & Pacific Market Share (2034F) | 21.4% |
| Key Companies Profiled | Allergan, Inc.; Hologic Inc.; MerzPharma; Revance Therapeutics Inc.; Alma Lasers; Cutera Inc.; Solta Medical; Lumenis; Johnson & Johnson; Galderma S.A.; Syneron Candela. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Why is Demand for Non-Invasive Aesthetic Treatment Surging?
“Growing Preference for Botox Injections in Cosmetology”
Botox injections are being accepted among cosmetology consumers, particularly the elderly, which is driving the demand for non-invasive aesthetic treatment solutions. Individuals over 50 years of age, especially women are contributing significantly to the increased demand for injections and fillers containing Botox. These shots are generally used to smooth wrinkles on the face. In addition, they target sebaceous oil glands within pores to minimize excessive sebum formulation and reduce sweat production, thereby preventing and improving acne formation.
What Could Inhibit Demand Growth for Non-Invasive Aesthetic Treatment Services?
“Inconsistent Results and High Cost of Non-Invasive Treatment”
Certain challenges are encountered by suppliers of non-invasive aesthetic treatment solutions because of their inconsistent results and high cost. Their higher costs are becoming a barrier for individuals with limited funds. In addition, there are variations in person-to-person outcomes, which leads to patient discontent.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What is Helping Startups Secure a Strong Hold in This Business Space?
“Advancements in Injection Techniques Ensuring Availability of Customized Treatments”
Advancements in injection technology are positively impacting non-invasive aesthetic treatment market trends. Innovations in injection techniques, such as personalized treatment plants and micro-dosing are leading to improved effectiveness and precision of the procedures, thereby enhancing outcomes and patient satisfaction. In addition, the development of new delivery systems and formulations is contributing to the easy availability of options for patients and practitioners, allowing for customized treatments.
Country-wise Insights
North America is forecasted to hold 36.1% share of global market revenue by the end of 2034, as revealed in the recently updated published report by Fact.MR, a market research and competitive intelligence provider. The prominence of the region is owing to the growing requirements for surgical procedures. An increased use of Botox injections is observed in North America, which is one of the key factors for market growth there.
Why are Non-Invasive Aesthetic Treatment Service Providers Targeting the United States?
“Availability of Ample Resources for Non-Invasive Aesthetic Treatments”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 11.79 Billion |
| Growth Rate (2024 to 2034) | 22.9% CAGR |
| Projected Value (2034F) | US$ 92.38 Billion |
The United States is analyzed to account for a share of 76.2% of the North American market by 2034. An increased adoption of injectables is contributing to expanding the non-invasive aesthetic treatment market size. Furthermore, a growing demand for beauty-enhancing procedures along with the availability of ample resources in the country is opening gates for market players.
Why are Companies Offering Non-Invasive Aesthetic Treatment Services Willing to Invest in India?
“Rising Awareness about Physical Appearance among Population”
| Attribute | India |
|---|---|
| Market Value (2024E) | US$ 2.16 Billion |
| Growth Rate (2024 to 2034) | 29.4% CAGR |
| Projected Value (2034F) | US$ 28.45 Billion |
India is approximated to capture 73.1% of the South Asia & Pacific market share by the end of 2034. Increasing consciousness about physical appearance among more consumers in the country is driving demand for non-invasive aesthetic treatment procedures.
Rising population of middle-class people led to greater accessibility and affordability of non-invasive beauty treatments, such as facial contouring, body sculpting, and skin rejuvenation, compared to conventional options. The increasing presence of youngsters, who are more inclined to personal grooming, self-care, and aesthetic enhancement is leading to the growing use of non-invasive aesthetic treatments.
What Makes South Korea a Key Market for Non-Invasive Aesthetic Treatment?
“High Spending on Beauty and Non-Invasive Aesthetic Procedures”
| Attribute | South Korea |
|---|---|
| Market Value (2024E) | US$ 1.36 Billion |
| Growth Rate (2024 to 2034) | 21.4% CAGR |
| Projected Value (2034F) | US$ 9.47 Billion |
South Korea is evaluated to contribute a share of 21% of the market in East Asia by 2034-end. Improving living standards is leading to increased consumer spending on various non-invasive aesthetic treatment procedures. Moreover, rising awareness about these treatments along with a desire to match set beauty standards are stimulating demand for non-invasive aesthetic procedures.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Through its recently updated analysis Fact.MR asserts that injectable non-invasive aesthetic treatments are becoming more popular owing to their ability to offer noticeable and rapid results with minimal recovery time. In addition, their cost-effectiveness, convenience, and adaptability to match individuals' requirements are making them a preferred option in the aesthetic sector.
Which Non-Invasive Aesthetic Treatment Procedure is Generating High Revenue?
“High Preference for Injectables Due to Their Less Downtime and Quick Results”
| Attribute | Injectables |
|---|---|
| Segment Value (2024E) | US$ 25.24 Billion |
| Growth Rate (2024 to 2034) | 21.3% CAGR |
| Projected Value (2034F) | US$ 173.83 Billion |
Injectables are projected to occupy 66.9% share of global market revenue by 2034. Increased demand for injectables by more surgeons is attributed to their ease of operations and ability to offer faster treatment with less downtime and quick results compared to other options, such as traditional ones.
Scarcity of collagen in the human body results in multiple problems, such as dry skin, gaining, wrinkles, and sagging skin. The growing awareness among more people about the use of collagen is contributing to its increased demand for cosmic surgery. Multiple properties of collagen, such as no or low side effects and quick wound healing are contributing to their increased use in injectables. Mexico, Italy, Brazil, and the United States are prominent countries contributing to increased demand for collagen injectables.
Why are Hospitals/Surgery Centers Preferred for Non-Invasive Aesthetic Treatment Procedures?
“Presence of Highly Skilled Experts and Medical Professionals Offering Personalized Services”
| Attribute | Hospitals/Surgery Centers |
|---|---|
| Segment Value (2024E) | US$ 16.08 Billion |
| Growth Rate (2024 to 2034) | 22.3% CAGR |
| Projected Value (2034F) | US$ 120.58 Billion |
Hospitals/surgery centers are calculated to possess a share of 46.4% of the global market by 2034. Increased demand for non-invasive aesthetic treatment devices in hospitals or surgery centers is due to their ability to offer a comprehensive array of aesthetic procedures to enhance appearance through non-surgical means. These facilities are well-known for their highly skilled medical professionals and experts offering individualized advice and guidance, instilling a sense of confidence and trust among patients opting for these services.
Competitive Landscape
Key players in the non-invasive aesthetic treatment market focus on strategies, such as geographic expansion, new product development, and improvement in existing technology to increase their profit share. Different development strategies assist them increase consumer awareness about new products and products.
For instance :
- Alma, in October 2020, introduced its Alma HybridTM. This new development aims to investigate multiple options for the use of ablative, thermal, and non-ablative therapies on scar revision and skin rejuvenation. In addition, this platform assesses the synthetic effects of these therapies, which contributes to the easy availability of technologically improved and user-friendly non-invasive aesthetic treatment solutions.
- In January 2021, Galderma launched Face for Change in partnership with The Skin Cancer Foundation and Dress for Success in the United States.
- In January 2021, The Frax Pro system was made available by Candela, a prominent worldwide medical aesthetic device manufacturer. It is a non-ablative fractional device and is FDA-approved and CE-marked.
Fact.MR provides detailed information about the price points of key non-invasive aesthetic treatment providers positioned across the world, sales growth, production capacity, and speculative technological expansion, in the recently updated market report.
Segmentation of Non-Invasive Aesthetic Treatment Market Research
-
By Procedure :
- Injectables
- Botulinum Toxin
- Calcium Hydroxylapatite
- Hyaluronic Acids
- Polymer Fillers
- Collagen
- Skin Rejuvenation
- Chemical Peel
- Laser Skin Resurfacing
- Photorejuvenation
- Others
- Hair Removal
- Nonsurgical Fat Reduction
- Sclerotherapy
- Cellulite Treatments
- Injectables
-
By End User :
- Hospitals/Surgery Centers
- MedSpas
- Traditional Spas
- CHP-Owned Clinics
-
By Region :
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia & Pacific
- MEA
- FAQs -
How big is the non-invasive aesthetic treatment market in 2024?
The global non-invasive aesthetic treatment market is valued at US$ 39.75 billion in 2024.
What are the projections for non-invasive aesthetic treatment services for 2034?
Worldwide demand for non-invasive aesthetic treatment services is forecasted to reach a market value of US$ 260 billion by 2034.
At what rate is the global market approximated to climb?
The global market is forecasted to expand at 20.7% CAGR from 2024 to 2034.
What is the contribution of North America to global market revenue?
North America is projected to capture 36.1% share of global market revenue by 2034.
At what CAGR is the demand for non-invasive aesthetic treatment services evaluated to increase in South Korea?
The market in South Korea is calculated to advance at a CAGR of 21.4% from 2024 to 2034.
How much share of the global market are injectables analyzed to account for?
Injectables are evaluated to hold 66.9% share of the global market by the end of 2034.
Who are the leading providers of non-invasive aesthetic treatment services?
Prominent market players are Allergan, Inc., Hologic Inc., MerzPharma, Alma Lasers, and Cutera Inc.
Non-Invasive Aesthetic Treatment Market